We are excited to launch the @CapsicoHealth AI Learning Lounge! To help healthcare executives and practitioners embed and integrate AI into their organizations, CapsicoHealth has launch an immersive project-based AI learning system for hospitals, payors and life sciences companies. The training leverage CapsicoHealth's cohort manager and AI models covering major disease areas and roles.
CapsicoHealth
医院和医疗保健
Palo Alto，California 285 位关注者
Real-World Intelligence for Patient Care and Outcomes
关于我们
CapsicoHealth was formed by experienced Al specialists, health informaticists, entrepreneurs and physicians to create a “hyperscale SaaS platform” providing real-world Intelligence for life sciences and healthcare organizations. Capsico offers the world's-first cloud-based AI workbench purpose-built for life-sciences and healthcare based on diverse healthcare data sets, and validated with a multitude of live and operational revenue, access and outcomes scenarios. Organizations are empowered to get insights quickly via curated health data and pre-built reports, with the option to leverage their internal data privately with Capsico’s AI Workbench to build (and maintain) scale models for a range of challenges. Customers can leverage state-of-the-art generative-AI frameworks (e.g., GPT, custom LLM models), and 250+ pre-built prediction models based on natural language processing (NLP) and neural network structures. Built by a team with experience in predictive modeling and big health data analysis, Capsico enables interactive tools to forecast revenue, compare treatments, identify market opportunities, gather adoption and provider network insights. Capsico’s pre-built data offering is based on trillions of data points from claims, de-identified records, studies, clinical trials, drug-outcomes, sponsorship data and provider registries. Capsico also enables analysts to rapidly generate new models, validate and derive insights through modern “no code” AI tools with high quality data and 99% automation. CapsicoHealth is proud to have been ranked by Becker's Health in the top 70 innovative companies in 2019. CapsicoHealth drive leadership in the community through thought leadership summits on role of AI in Healthcare and Pharma. Our team is diverse and worked at places like IBM Watson Research, The Advisory Board, Optum, MD Anderson Cancer Center, McKesson, Accenture, Merck, Stanford University and Carnegie Mellon University.
- 网站
-
https://www.CapsicoHealth.com
CapsicoHealth的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 11-50 人
- 总部
- Palo Alto，California
- 类型
- 私人持股
- 领域
- AI、Population Risk和Large Scale Analytics
地点
CapsicoHealth员工
-
Ann K. Klein
Healthcare Software CEO/CPO/GM, Executive Advisor, and Board Member
-
Arun Villivalam MD MBA
-
Laurent Hasson
Co-Founder, CTO at CapsicoHealth Inc
-
Jonathan Meek
Managing Director: Precision Healthcare Strategies LLC. Global Leader in Patient Impact Initiatives | Precision Medicine | AI Strategy | Start-Up…
动态
-
CapsicoHealth is very excited to announce our next version of Gen-AI based Patient Pathway analyses and prediction tools for precision-medicine in Oncology, and in specific Radioligand ?therapies for Cancer Care. ? We are also extremely pleased to announce the acceptance of our Gen-AI driven pathway analyses method for precision-care for a podium presentation at the prestigious INFORMS conference, 2024, Seattle.
Every year over 250,000 men are diagnosed with Prostate cancer, contributing to more than 30,000 annual deaths, a 5-year survival rate of only 30%.??Prostate-specific membrane antigen (PSMA) targeted PET tracers, along with Radioligand Therapy (RLT) represents a promising new approach to Prostate Cancer treatment in advanced precision-medicine, with 50% reduction in PSA and survival improvement of over 30%. CapsicoHealth is very excited to announce our next version of Gen-AI based Patient Pathway analyses and prediction tools for precision-medicine in Oncology, and in specific Radioligand ?therapies for Cancer Care. ??We are also extremely pleased to announce the acceptance of our Gen-AI driven pathway analyses method for precision-care for a podium presentation at the prestigious INFORMS conference, 2024, Seattle.?CapsicoHealth’s Context-aware LLM tools predict patient pathways including identifying at-risk patients for early treatment, potentially predicting disease progression and driving critical insights for care and supply chain planning.
-
-
CapsicoHealth is very excited to announce our next version of Gen-AI based Patient Pathway analyses and prediction tools for precision-medicine in Oncology, and in specific Radioligand ?therapies for Cancer Care. ? We are also extremely pleased to announce the acceptance of our Gen-AI driven pathway analyses method for precision-care for a podium presentation at the prestigious INFORMS conference, 2024, Seattle.
Every year over 250,000 men are diagnosed with Prostate cancer, contributing to more than 30,000 annual deaths, a 5-year survival rate of only 30%.??Prostate-specific membrane antigen (PSMA) targeted PET tracers, along with Radioligand Therapy (RLT) represents a promising new approach to Prostate Cancer treatment in advanced precision-medicine, with 50% reduction in PSA and survival improvement of over 30%. CapsicoHealth is very excited to announce our next version of Gen-AI based Patient Pathway analyses and prediction tools for precision-medicine in Oncology, and in specific Radioligand ?therapies for Cancer Care. ??We are also extremely pleased to announce the acceptance of our Gen-AI driven pathway analyses method for precision-care for a podium presentation at the prestigious INFORMS conference, 2024, Seattle.?CapsicoHealth’s Context-aware LLM tools predict patient pathways including identifying at-risk patients for early treatment, potentially predicting disease progression and driving critical insights for care and supply chain planning.
-
-
Every year over 250,000 men are diagnosed with Prostate cancer, contributing to more than 30,000 annual deaths, a 5-year survival rate of only 30%.??Prostate-specific membrane antigen (PSMA) targeted PET tracers, along with Radioligand Therapy (RLT) represents a promising new approach to Prostate Cancer treatment in advanced precision-medicine, with 50% reduction in PSA and survival improvement of over 30%. CapsicoHealth is very excited to announce our next version of Gen-AI based Patient Pathway analyses and prediction tools for precision-medicine in Oncology, and in specific Radioligand ?therapies for Cancer Care. ??We are also extremely pleased to announce the acceptance of our Gen-AI driven pathway analyses method for precision-care for a podium presentation at the prestigious INFORMS conference, 2024, Seattle.?CapsicoHealth’s Context-aware LLM tools predict patient pathways including identifying at-risk patients for early treatment, potentially predicting disease progression and driving critical insights for care and supply chain planning.
-
-
VC (Venture Capital) | Global Supply Chain Leader | Advisory Board Member | Angel Investor | Venture Partner | Start-Up Advisor | Ex-Alcon | Ex-Pfizer | ISB | Cranfield | VJTI
As a Board Advisory Member of Kare AI Inc., I am pleased to share an exciting milestone in the intersection of AI and leadership development. On 6th September, Kare AI Inc. in partnership with NVIDIA and CapsicoHealth, will launch India’s first hands-on training in Generative AI, hosted at the esteemed Indian School of Business' ISB Institute of Data Science (IIDS), Hyderabad as the Venue Partner. This initiative is a significant step forward in equipping around 70 senior leaders from India’s top organizations with the tools and knowledge to navigate and lead in the rapidly evolving landscape of AI-driven innovation. Key Highlights of the Workshop: NVIDIA: Delivering an intensive 6-hour training session on Generative AI, culminating in a highly regarded certification for all participants. CapsicoHealth: Conducting a Stanford University-themed AI workshop, enriched with capstone projects, real-world assignments, and live case studies. Kare AI Inc.: Offering comprehensive training on our full-stack Gen AI platform, with extended access for 6 months to empower organizations in implementing advanced AI solutions. This collaboration is not just about learning; it’s about leading. It represents our collective commitment to advancing through innovative technologies and fostering a new generation of AI leaders. For those ready to be at the forefront of this transformation, I encourage you to register and be part of this pivotal event. ?? Website: https://lnkd.in/daivkK6x | Registration: https://lnkd.in/dTpRTmEZ StartupNews.fyi is the Media Partner for the event. Please reach out to Koustav Chatterjee ([email protected]) for queries/information related to the workshop. Koustav Chatterjee J (Ramesh) Sairamesh Indian School of Business #AILeadership #GenerativeAI #Innovation #NVIDIA #CapsicoHealth #KareAI #ISBHyderabad Madhur Mohan M.
-
New open source release.
Tilda v2.5.1 was released a few weeks ago but didn't get a chance yet to talk about it. https://lnkd.in/gxXzbSPJ This release's main feature is a significant extension of the DATETIME type to implement richer timezone semantics. Handling Timezones is always a complex endeavor (don't trust people who say it's nothing!) and with this release, more expected behavior is baked in the platform. We have also strengthened masking rules to make dynamic data masking more powerful. And finally, we implemented some major performance enhancement in our simple command-line-based data transfer capabilities between #Postgres and #BigQuery. There are also opportunities to contribute and i can spend time mentoring newcomers. In particular, our build environment is not great. Someone who knows how to do it right in GitHub and Gradle would be very welcome!
Release v2.5.1 · CapsicoHealth/Tilda
github.com
-
As more Gen AI companies emerge to serve the enterprise, the ones that are winning have built robust applications, often with external data married to enterprise data for true business intelligence. CapsicoHealth CEO J (Ramesh) Sairamesh spoke about the many building blocks to create a robust prescribing pattern analytics solution at this week’s Gen AI Summit in SF. #AI
Our CEO J (Ramesh) Sairamesh spoke this week at the GenAI Sunmmit San Francisco about CapsicoHealth and our innovative approach to uncovering treatment and prescribing patterns using AI-powered, specially-curated patient journeys. Great conference to share and learn from other innovators Zachary Lipton ( Abridge ) Shyam Rajagopalan (Infinitus Systems, Inc. ) Natalia Vassilieva ( Cerebras Systems )
-